|
2023
|
Invention
|
Method of treating hypertension with the aldosterone synthase inhibitor baxdrostat. The disclosur... |
|
|
Invention
|
Method of treating hypertension with the aldosterone synthase inhibitor baxdrostat |
|
2022
|
Invention
|
Methods of using aldosterone synthase inhibitors.
The disclosure provides methods of inhibiting ... |
|
|
Invention
|
Methods of using aldosterone synthase inhibitors. The disclosure provides methods of inhibiting h... |
|
2017
|
Invention
|
Dihydroquinoline pyrazolyl compounds. The invention provides novel compounds having the general f... |
|
|
Invention
|
Pyridinyloxy- and phenyloxy-pyrazolyl compounds. The invention provides novel compounds having th... |
|
|
Invention
|
Spirodiamine derivatives as aldosterone synthase inhibitors. The invention provides novel compoun... |
|
2016
|
Invention
|
Phenyl-dihydropyridine derivatives as aldosterone synthase inhibitors. The invention provides nov... |
|
|
Invention
|
Phenyl-dihydropyridine derivatives as inhibitors of aldosterone synthase. The invention provides ... |
|
2015
|
Invention
|
3,4-dihydro-2h-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compounds. The invention provide... |
|
|
Invention
|
Dihydroquinoline-2-one derivatives. The invention provides novel compounds having the general for... |
|
2013
|
Invention
|
Phenyl-tetrahydroisoquinoline derivatives. The invention provides novel compounds having the gene... |
|
|
Invention
|
Imidazolylketone derivatives. The invention provides novel compounds having the general formula (... |
|
2012
|
Invention
|
Bicyclic dihydroisoquinoline-1-one derivatives. The invention provides novel compounds having the... |
|
|
Invention
|
Bicyclic dihydroquinoline-2-one derivatives. The invention provides novel compounds having the ge... |
